Total submissions: 3
| Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
|---|---|---|---|---|---|---|---|---|
| Labcorp Genetics |
RCV000692430 | SCV000820255 | uncertain significance | LAMA2-related muscular dystrophy | 2018-04-18 | criteria provided, single submitter | clinical testing | This sequence change replaces histidine with asparagine at codon 1441 of the LAMA2 protein (p.His1441Asn). The histidine residue is moderately conserved and there is a small physicochemical difference between histidine and asparagine. This variant is not present in population databases (ExAC no frequency). This variant has not been reported in the literature in individuals with LAMA2-related disease. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated, but these predictions have not been confirmed by published functional studies and their clinical significance is uncertain. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
| Athena Diagnostics | RCV000712187 | SCV000842618 | uncertain significance | not provided | 2018-10-10 | criteria provided, single submitter | clinical testing | |
| Breakthrough Genomics, |
RCV000712187 | SCV005189234 | uncertain significance | not provided | criteria provided, single submitter | not provided |